{"nct_id":"NCT04484935","title":"Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children","status":"COMPLETED","status_verified_date":"2023-10","start_date":"2020-08-19","start_date_type":"ACTUAL","primary_completion_date":"2023-02-17","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AZN"]}